Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-921-6 | CAS number: 3282-30-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Pivanoyl chloride is of low systemic toxicity after dermal contact. Due to its causic properties the substance is of moderate toxicity after ingestion. Pivanoyl chloride is toxic via inhalation.
Key value for chemical safety assessment
Additional information
oral:
Sprague-Dawley rats (5/sex/dose) were exposed to pivaloyl chloride via gavage at doses of 500, 650 or 800 mg/kg-bw and observed for 14 days (Stillmeadow, 1986). The number of deaths (and time of death) was as follows: 2/10 at 500 mg/kg,4/10 at 650 mg/kg and 9/10 at 800 mg/kg. Necropsy findings observed reflect the caustic propreties of the substance. The LD50was 638 mg/kg bw.
In a guideline study (OECD TG 401), Sprague-Dawley rats (5/sex/dose) were exposed to pivaloyl chloride in olive oil via gavage at doses of 316, 681, 1000, 1470, 2150, 3160 mg/kg-bw and observed for 14 days (BASF, 1981). There were no deaths or clinical signs of toxicity at 316 and 681mg/kg; there were also no deaths at 1000 mg/kg. At 1470 mg/kg, 4/10 animals died. At the two highest doses, all animals died. Animals that died during the observation period showed haemorrhage in stomach and intestines. Necropsy findings observed reflect the caustic propreties of the substance. The estimated LD50 values in males, females and combined sexes are ca. 1470, ca. 1330, and ca. 1470 mg/kg bw, respectively.
dermal:
In a study similar to OECD TG 402, white rabbits (5/sex) were exposed via the dermal route, under a semi-occlusive cover, to 2010 mg/kg-bw pivaloyl chloride for 24 hours. Animals were observed for mortality and signs of toxicity for 14 days post exposure (Stillmeadow, 1987). Gross necropsy findings in the one animal that died included extensive ulceration throughout the exposed area. The dermal LD50 value is greater than 2010 mg/kg bw.
inhalation:
In a study similar to OECD TG 403, Sprague-Dawley rats (5/sex/concentration) were exposed to pivaloyl chloride as an aerosol for one hour at 1.14, 1.47, 2.28 (males only), 2.57, 2.75 or 5.15 mg/L and observed for 14 days (Stillmeadow, 1987a). The test material was generated as an aerosol. However, the material the animals were exposed to may have been vapor indicated by the volatility of the material, lack of particles collected when particle sizing was attempted and visual inspection of the chamber. The number of deaths (and time of death) was as follows: no deaths at 1.14, 1.47 and 2.28 mg/L; at 2.57 mg/L: 3/5 males (within Day 1); at 2.75 mg/L: 4/5 males and 2/5 females; and at 5.15 mg/L all animals died. Gross necropsy findings in animals that died before study termination included signs of lacrimation, nasal discharge, discoloration of lungs. The 1-hr LC50 is 2.69 mg/L (combined sexes). According to EC/1272/2008 Annex I, 3.1.2.1.b the 4hr-LC50 is calculated for vapour by dividing by factor 2: 4h-LC50 = 1.35 mg/L.
In a guideline study (OECD TG 403), Sprague-Dawley rats (5/sex/concentration) were exposed via nose only for 4 hours to pivaloyl chloride at 0, 1.43 or 1.646 mg/L (0, 232 and 334 ppm) and observed for 14 days (Hazelton, 1988). All animals survived at 1.43 mg/L while all animals died at 1.646 mg/L. Clinical signs attributable to treatment were observed for two days post-exposure and included lacrimation, salivation, hunched posture, lethargy and respiratory distress. All animals that died had increased lung weights; gross findings included inflated lungs that were red or dark with white frothy fluid in the trachea, which is likely a sign of lung oedema. At termination, animals exposed to 1.43 mg/L had similar lung weights as controls; necropsies were unremarkable. The 4-hr LC50 was between 1.43 and 1.65 mg/L.
Justification for classification or non-classification
Based on the available data a classification concerning acute inhalation toxicity (acute inhal. Cat 2) is warranted according to regulatin 1272/2008/EC.
Oral toxicity is a secondary effect of the caustic properties of the substance, however labeled as acute oral Cat 4.
No classification suggested for acute dermal toxicity as criteria of regulation 1272/2008/EC are not met.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.